Efficacy of First Line DRC +/- Bortezomib for Patients With Waldenström's Macroglobulinemia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01788020 |
Recruitment Status :
Completed
First Posted : February 11, 2013
Last Update Posted : May 13, 2024
|
Sponsor:
University of Ulm
Collaborator:
Centre Hospitalier de Lens (Co-Sponsor)
Information provided by (Responsible Party):
Christian Buske, University of Ulm
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | November 2018 |
Actual Study Completion Date : | April 2024 |